In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations.
Inhaltsverzeichnis
I Pathophysiology. - 1 The Spectrum of Myocardial Ischemia: The Paradigm of Acute Coronary Syndromes. - 2 Linking Biochemistry, Vascular Biology, and Clinical Events in Acute Coronary Syndromes. - 3 Triggers of Acute Coronary Syndromes. - 4 Insights into the Pathophysiology of Acute Ischemia Syndromes Using the TIMI Flow Grade, TIMI Frame Count, and TIMI Myocardial Perfusion Grade. - II Diagnosis. - 5 Emergency Department Presentations of Acute Cardiac Ischemia. - 6 Early Identification and Treatment of Patients with Acute Coronary Syndromes. - 7 Serum Markers for Diagnosis and Risk Stratification in Acute Coronary Syndromes. - 8 Technologies to Diagnose Acute Ischemia. - III ST-Segment Elevation Myocardial Infarction. - 9 Thrombolytic Therapy. - 10 Primary Angioplasty. - 11 Expanding the Access to Percutaneous Coronary Intervention for Patients Admitted to Community Hospitals. - 12 Antiplatelet and Anticoagulant Therapy. - 13 ? -Adrenergic Blockers, Calcium Channel Blockers, and Nitrates. - 14 Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction. - 15 Risk Stratification: Exercise Testing, Imaging, and Cardiac Catheterization. - IV Non-ST-Segment Elevation Myocardial Infarction. - 16 Anticoagulant Therapies. - 17 Antiplatelet Therapy. - 18 Thrombolytics and Invasive vs Conservative Strategies in Unstable Angina. - 19 Current Device Strategies in the Management of Acute Coronary Syndromes. - V Special Aspects of Acute Coronary Syndromes. - 20 Women and Acute Coronary Syndromes. - 21 The Modern Strategy for Cardiogenic Shock. - 22 Myocardial Infarction in the Younger Patient. - 23 Cholesterol Lowering. - 24 Secondary Prevention of Myocardial Infarction. - 25 Cost and Cost-Effectiveness in Acute Coronary Syndromes. - 26Smoking Cessation. - 27 Critical Pathways for Acute Coronary Syndromes.